已发表论文

TREM1 变异对中国汉族人群胶质瘤风险和预后的影响

 

Authors Hu M, Wei J, Hao J, Jin T, Li B

Received 6 January 2023

Accepted for publication 21 April 2023

Published 3 July 2023 Volume 2023:16 Pages 707—715

DOI https://doi.org/10.2147/PGPM.S403870

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Martin H Bluth

Background: Glioma is the main pathological subtype of brain tumors with high mortality.
Objective: This study aimed to elucidate the correlation between TREM1 variants and glioma risk in the Chinese Han population.
Methods: Genotyping of six variants of TREM1 was completed by Agena MassARRAY platform in 1061 subjects (503 controls and 558 glioma patients). The relationship between TREM1 polymorphisms and glioma risk was calculated using the logistic regression model, with odds ratio (OR) and 95% confidence intervals (CIs). A multifactor dimensionality reduction (MDR) method was performed to assess SNP–SNP interactions to predict glioma risk.
Results: In this research, overall analysis illustrated an association between TREM1 rs9369269 and an increased risk of glioma. Rs9369269 was also related to the risk of glioma in patients aged ≤ 40 years and females. Subjects with rs9369269 AC genotype were likely to obtain glioma compared to people with CC genotype (patients with astroglioma vs healthy people). Compared to TT genotype carriers, carriers with AT genotype of rs1351835 were significantly associated with overall survival (OS).
Conclusion: Taken together, the study identified the association between TREM1 variants and glioma risk and TREM1 variants were significantly associated with the prognosis of glioma. In the future, larger samples are needed to verify the results.
Keywords: glioma, TREM1 , single nucleotide polymorphisms, risk